Blood Plasma Product

14) A reconstituted previously spray dried plasma made from rehydrating a spray dried plasma with water, wherein the spray dried plasma is made from donor plasma from one or more donors;

• the reconstituted previously spray dried plasma comprises:
• a) a pH ranging from about 6.7 to about 7.8, and
• b) an amount of von Willebrand Ristocetin Cofactor VWF:RCo) ranging from about 10 to about 200 IU/dL, or an amount of von Willebrand Factor Antigen (VWF:Ag) ranging from about 50 to 200 IU/dL;
• and
• c) a plasma characteristic selected from the group consisting of:
• i) a reduced mean size of particulates when measured with a cell analyzer using an electrical sensing zone method for particulates having a size ranging from about 2 μm to 60 μm, as compared to the mean size of particulates in the donor plasma;
• ii) a reduced number of cholesterol crystals, when viewed at 100× magnification, as compared to reconstituted freeze dried plasma;
• iii) stability for transfusion, after storage for up to 24 hours;
• and
• iv) a combination thereof,
• wherein the reconstituted previously spray dried plasma allows for clot formation.

17) A reconstituted previously spray dried plasma made from rehydrating a spray dried plasma with water, wherein the spray dried plasma is made from donor plasma from one or more donors;

• the reconstituted previously spray dried plasma comprises:
• a) a pH ranging from about 6.7 to about 7.8, and
• b) an amount of von Willebrand Ristocetin Cofactor VWF:RCo) ranging from about 10 to about 200 IU/dL, or an amount of von Willebrand Factor Antigen (VWF:Ag) ranging from about 50 to 200 IU/dL;
• and
• c) a plasma characteristic selected from the group consisting of:
• i) a reduced mean size of particulates when measured with a cell analyzer using an electrical sensing zone method for particulates having a size ranging from about 2 μm to 60 μm, as compared to the mean size of particulates in the donor plasma;
• ii) a reduced number of cholesterol crystals, when viewed at 100× magnification, as compared to reconstituted freeze dried plasma;
• iii) stability for transfusion, after storage for up to 24 hours;
• and
• iv) a combination thereof;
• and
• d) wherein the spray dried plasma, prior to hydration, has a plasma characteristic selected from the group consisting of:
• i) dried plasma particles having a size ranging from about 1 to about 7 μm;
• ii) residual moisture in a range from about 0.5% to about 2.5%;
• iii) stable when stored for a period of time ranging from about 1 day to about 48 months at a temperature ranging from about 1° C. to about 45° C., as compared to reconstituted previously spray dried plasma before storage;
• and
• iv) a combination thereof,
• wherein the reconstituted previously spray dried plasma allows for clot formation.